(Q40005186)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18323795%20AND%20SRC:MED&resulttype=core&format=json

3 January 2020

title

Development of an enhanced B-specific lentiviral vector expressing BTK: a tool for gene therapy of XLA (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18323795%20AND%20SRC:MED&resulttype=core&format=json

3 January 2020

0 references

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18323795%20AND%20SRC:MED&resulttype=core&format=json

3 January 2020

Jacques A Nunes

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18323795%20AND%20SRC:MED&resulttype=core&format=json

3 January 2020

author name string

V Barlogis

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18323795%20AND%20SRC:MED&resulttype=core&format=json

3 January 2020

F Bardin

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18323795%20AND%20SRC:MED&resulttype=core&format=json

3 January 2020

B Calmels

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18323795%20AND%20SRC:MED&resulttype=core&format=json

3 January 2020

C Chabannon

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18323795%20AND%20SRC:MED&resulttype=core&format=json

3 January 2020

C Tonnelle

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18323795%20AND%20SRC:MED&resulttype=core&format=json

3 January 2020

publication date

6 March 2008

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18323795%20AND%20SRC:MED&resulttype=core&format=json

3 January 2020

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18323795%20AND%20SRC:MED&resulttype=core&format=json

3 January 2020

volume

15

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18323795%20AND%20SRC:MED&resulttype=core&format=json

3 January 2020

issue

12

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18323795%20AND%20SRC:MED&resulttype=core&format=json

3 January 2020

page(s)

942-952

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18323795%20AND%20SRC:MED&resulttype=core&format=json

https://scigraph.springernature.com/pub.10.1038/gt.2008.17

3 January 2020

exact match

0 references

cites work

Sustained correction of X-linked severe combined immunodeficiency by ex vivo gene therapy

1 reference

https://api.crossref.org/works/10.1038%2FGT.2008.17

Gene therapy of X-linked severe combined immunodeficiency by use of a pseudotyped gammaretroviral vector

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGT.2008.17

Correction of ADA-SCID by stem cell gene therapy combined with nonmyeloablative conditioning

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGT.2008.17

Correction of X-linked chronic granulomatous disease by gene therapy, augmented by insertional activation of MDS1-EVI1, PRDM16 or SETBP1.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGT.2008.17

Transcription start regions in the human genome are favored targets for MLV integration

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGT.2008.17

Distinct genomic integration of MLV and SIV vectors in primate hematopoietic stem and progenitor cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGT.2008.17

Gene therapy for severe combined immunodeficiency: are we there yet?

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGT.2008.17

In vivo gene delivery and stable transduction of nondividing cells by a lentiviral vector

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGT.2008.17

Transduction of nondividing cells using pseudotyped defective high-titer HIV type 1 particles

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGT.2008.17

HIV, but not murine leukemia virus, vectors mediate high efficiency gene transfer into freshly isolated G0/G1 human hematopoietic stem cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGT.2008.17

Stable transduction of quiescent CD34(+)CD38(-) human hematopoietic cells by HIV-1-based lentiviral vectors

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGT.2008.17

Advances in lentiviral vector design for gene-modification of hematopoietic stem cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGT.2008.17

Hematopoietic stem cell gene transfer in a tumor-prone mouse model uncovers low genotoxicity of lentiviral vector integration

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGT.2008.17

Gene transfer in humans using a conditionally replicating lentiviral vector

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGT.2008.17

A phase I/II clinical trial of beta-globin gene therapy for beta-thalassemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGT.2008.17

Genetic analysis of patients with defects in early B-cell development

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGT.2008.17

The gene involved in X-linked agammaglobulinaemia is a member of the src family of protein-tyrosine kinases

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGT.2008.17

Deficient expression of a B cell cytoplasmic tyrosine kinase in human X-linked agammaglobulinemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGT.2008.17

Mutation of unique region of Bruton's tyrosine kinase in immunodeficient XID mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGT.2008.17

Potential application of gene therapy to X-linked agammaglobulinemia.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGT.2008.17

Sustained correction of B-cell development and function in a murine model of X-linked agammaglobulinemia (XLA) using retroviral-mediated gene transfer

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGT.2008.17

Restriction of transgene expression to the B-lymphoid progeny of human lentivirally transduced CD34+ cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGT.2008.17

Dependence of enhancer-mediated transcription of the immunoglobulin mu gene on nuclear matrix attachment regions

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGT.2008.17

Expression of the (recombinant) endogenous immunoglobulin heavy-chain locus requires the intronic matrix attachment regions

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGT.2008.17

Extension of chromatin accessibility by nuclear matrix attachment regions.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGT.2008.17

The immunoglobulin heavy-chain matrix-associating regions are bound by Bright: a B cell-specific trans-activator that describes a new DNA-binding protein family

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGT.2008.17

The Ser36-Ser37 Pair in HeLa Nuclear Protein p21/SIIR Mediates Ser/Thr Phosphorylation and Is Essential for Rous Sarcoma Virus Long Terminal Repeat Repression

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGT.2008.17

A tissue-specific MAR/SAR DNA-binding protein with unusual binding site recognition

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGT.2008.17

A developmental-specific factor binds to suppressor sites flanking the immunoglobulin heavy-chain enhancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGT.2008.17

Lentivirus vectors incorporating the immunoglobulin heavy chain enhancer and matrix attachment regions provide position-independent expression in B lymphocytes

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGT.2008.17

Development of functional human blood and immune systems in NOD/SCID/IL2 receptor {gamma} chain(null) mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGT.2008.17

Bruton tyrosine kinase is tyrosine phosphorylated and activated in pre-B lymphocytes and receptor-ligated B cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGT.2008.17

B-cell-specific transgene expression using a self-inactivating retroviral vector with human CD19 promoter and viral post-transcriptional regulatory element

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGT.2008.17

Cell-specific and efficient expression in mouse and human B cells by a novel hybrid immunoglobulin promoter in a lentiviral vector.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGT.2008.17

Integrated self-inactivating lentiviral vectors produce full-length genomic transcripts competent for encapsidation and integration

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGT.2008.17

Rac2 stimulates Akt activation affecting BAD/Bcl-XL expression while mediating survival and actin function in primary mast cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGT.2008.17

Bruton's tyrosine kinase: cell biology, sequence conservation, mutation spectrum, siRNA modifications, and expression profiling.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGT.2008.17

Correction of the X-linked immunodeficiency phenotype by transgenic expression of human Bruton tyrosine kinase under the control of the class II major histocompatibility complex Ea locus control region

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGT.2008.17

Appearance of human plasma cells following differentiation of human B cells in NOD/SCID mouse spleen

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGT.2008.17

Btk/Tec kinases regulate sustained increases in intracellular Ca2+ following B-cell receptor activation

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGT.2008.17

Ex vivo generation of fully mature human red blood cells from hematopoietic stem cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGT.2008.17

Development of a self-inactivating lentivirus vector.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGT.2008.17

7 January 2021

Colocalization of X-linked agammaglobulinemia and X-linked immunodeficiency genes

1 reference

https://api.crossref.org/works/10.1038%2FGT.2008.17

7 January 2021

The health status and quality of life of adults with X-linked agammaglobulinemia

1 reference

https://api.crossref.org/works/10.1038%2FGT.2008.17

7 January 2021

X-Linked Agammaglobulinemia

1 reference

https://api.crossref.org/works/10.1038%2FGT.2008.17

7 January 2021

Mutually exclusive interaction of a novel matrix attachment region binding protein and the NF-muNR enhancer repressor. Implications for regulation of immunoglobulin heavy chain expression

1 reference

https://api.crossref.org/works/10.1038%2FGT.2008.17

7 January 2021

Tec kinases: a family with multiple roles in immunity

1 reference

https://api.crossref.org/works/10.1038%2FGT.2008.17

7 January 2021

Bruton's tyrosine kinase is not essential for LPS-induced activation of human monocytes

1 reference

https://api.crossref.org/works/10.1038%2FGT.2008.17

7 January 2021

Enhanced transgene expression in cord blood CD34(+)-derived hematopoietic cells, including developing T cells and NOD/SCID mouse repopulating cells, following transduction with modified trip lentiviral vectors

1 reference

https://api.crossref.org/works/10.1038%2FGT.2008.17

7 January 2021

Identifiers

DOI

10.1038/GT.2008.17

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18323795%20AND%20SRC:MED&resulttype=core&format=json

Dimensions Publication ID

3 January 2020

0 references

1 reference